Wealth Enhancement Advisory Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.61M | Sell |
100,986
-16,442
| -14% | -$1.4M | 0.01% | 687 |
|
|
2025
Q1 | $9.52M | Sell |
117,428
-1,419
| -1% | -$115K | 0.02% | 599 |
|
|
2024
Q4 | $10.7M | Buy |
118,847
+284
| +0.2% | +$25.6K | 0.02% | 538 |
|
|
2024
Q3 | $11.7M | Buy |
118,563
+4,625
| +4% | +$457K | 0.03% | 477 |
|
|
2024
Q2 | $10.6M | Sell |
113,938
-695
| -0.6% | -$64.4K | 0.03% | 476 |
|
|
2024
Q1 | $10.9M | Buy |
114,633
+9,383
| +9% | +$890K | 0.03% | 452 |
|
|
2023
Q4 | $9.4M | Sell |
105,250
-3,026
| -3% | -$270K | 0.03% | 449 |
|
|
2023
Q3 | $7.91M | Buy |
+108,276
| New | +$7.91M | 0.03% | 464 |
|